Virtual Clinical Trials Market is Projected to Grow Expeditiously: to Reach $19.51 Billion by 2029

 Created for forward-thinking professionals, this report equips teams with the insights needed to compete effectively in the virtual clinical trials space.

How Much Is The Virtual Clinical Trials Market Worth?
The virtual clinical trials market size has grown strongly in recent years. It will grow from $11.91 billion in 2024 to $12.95 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased costs of clinical trials, growing need for patient-centric trials, increased demand for remote monitoring, growing adoption of digital technologies in clinical trials, increased need for efficient and cost-effective clinical trial.

The virtual clinical trials market size is expected to see rapid growth in the next few years. It will grow to $19.51 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to growing adoption of decentralized clinical trials, increasing use of wearables and other remote monitoring devices, expansion of telehealth services, regulatory support for virtual trial methodologies, cost and time efficiency in trial conduct. Major trends in the forecast period include increasing use of artificial intelligence and machine learning in clinical trials, increased use of electronic informed consent (econsent), growth in virtual trial platforms and technologies, collaboration between pharmaceutical companies and technology providers, focus on real-world evidence and decentralized data collection.

Get your free sample today:
Virtual Clinical Trials Market Report 2025, Outlook & Demand 2034 Sample

What Are The Current Leading Growth Drivers For Virtual Clinical Trials Market?
The increasing investments by the government and pharmaceutical companies in the R&D for the development of new vaccines and drugs are driving the growth of the virtual clinical trials market. The R&D divisions in the medical industry are increasingly utilizing virtual clinical trial solutions and services to increase quality assurance and clinical data management of drugs and their products. According to an article published by McKinsey, COVID-19 pandemic, has catalyzed the adoption of decentralized clinical trials by pharma companies while highlighting the critical benefits of virtual trials and improving the patient and physician experience. Therefore, the increasing investments by the government and pharmaceutical companies in new vaccines and drug development are driving the growth of virtual clinical trials.

Which Segment Accounted For The Largest Virtual Clinical Trials Market Share?
The virtual clinical trialsmarket covered in this report is segmented –

1) By Design: Observational Trials, Interventional Trials, Expanded Access Trials
2) By Phases: Phase I, Phase II, Phase III, Phase IV
3) By Indication: CNS, Autoimmune Or Inflammation, Cardiovascular Disease, Metabolic Or Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications

Subsegments:
1) By Observational Trials: Prospective Cohort Studies, Retrospective Studies, Case-Control Studies
2) By Interventional Trials: Randomized Controlled Trials (RCTs), Non-Randomized Trials, Adaptive Trials
3) By Expanded Access Trials: Single-Patient Expanded Access, Multi-Patient Expanded Access, Compassionate Use Programs

Virtual Clinical Trials Market Emerging Trends And Opportunities
Technology advancement is a key trend gaining popularity in the virtual clinical trials market. Major companies operating in the virtual clinical trials market are focused on providing technologically advanced solutions to meet fast-growing industry demands and strengthen their market position. These companies are implementing new generation virtual clinical technologies into their services, such as wearable technologies, mHealth, blockchain, cloud computing, EMR integration, actionable data, threshold monitoring, AI, SFTP, ETL services, and others. For instance, in April 2022, Unlearn. AI, a US-based startup, will launch a new digital twin RCTs technology for clinical trials that enables smaller control groups while maintaining power and generating evidence suitable for supporting regulatory decisions using AI and historical data.

Which Are The Top Companies To Hold The Market Share In Virtual Clinical Trials Market?
Major companies operating in the virtual clinical trials market include ICON plc, Parexel International Pvt. Ltd., IQVIA Holdings Inc., Covance Research Products Inc., Pharmaceutical Research Associates Inc., Medidata Solution Inc., Oracle Corporation, Clario Tech Ltd., Medable Inc., Science 37 Holdings Inc., THREAD Research, Clinical Ink Inc., Veeva Systems Inc., Clinerion Ltd., CRF Health Group Limited, Royal Castor Products Limited, Crio Inc., Deep Lens Inc., Florence Healthcare Inc., goBalto Inc., Medrio Inc., Mint Medical Ltd., Mytrus Inc., OpenClinica LLC, PatientWing, RealTime-CTMS LLC, Reify Health, Sanguine Biosciences Inc., TriNetX Inc., VirTrial LLC

View the full virtual clinical trials market report here:
Virtual Clinical Trials Market Report 2025, Outlook & Demand 2034

Which Region Is Projected To Account For The Largest Share Of The Virtual Clinical Trials Market?
North America was the largest region in the virtual clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn